Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Proceedings of the ... IEEE Conference on Decision & Control. IEEE Conference on Decision & Control
|
March 20, 2019
Controlling organism size by regulating constituent cell numbers
Saurabh Modi, Abhyudai Singh
Plos Computational Biology
|
July 28, 2021
Noise suppression in stochastic genetic circuits using PID controllers
Saurabh Modi, Supravat Dey, Abhyudai Singh
Biophysical Journal
|
June 8, 2017
Analysis of Noise Mechanisms in Cell-Size Control
Saurabh Modi, Cesar Augusto Vargas-Garcia, Khem Raj Ghusinga, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 23, 2024
A novel Bayesian generative approach for estimating tumor dynamics from published studies
Arya Pourzanjani, Saurabh Modi, Jamie Connarn, et al.
Journal of Clinical Pharmacology
|
August 6, 2025
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T-Cell Engager, in Prostate Cancer Patients
Jamie N Kuipers-Connarn, Arya Pourzanjani, Maitreyee Bose, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Proceedings of the ... IEEE Conference on Decision & Control. IEEE Conference on Decision & Control
|
March 20, 2019
Controlling organism size by regulating constituent cell numbers
Saurabh Modi, Abhyudai Singh
Plos Computational Biology
|
July 28, 2021
Noise suppression in stochastic genetic circuits using PID controllers
Saurabh Modi, Supravat Dey, Abhyudai Singh
Biophysical Journal
|
June 8, 2017
Analysis of Noise Mechanisms in Cell-Size Control
Saurabh Modi, Cesar Augusto Vargas-Garcia, Khem Raj Ghusinga, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 23, 2024
A novel Bayesian generative approach for estimating tumor dynamics from published studies
Arya Pourzanjani, Saurabh Modi, Jamie Connarn, et al.
Journal of Clinical Pharmacology
|
August 6, 2025
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T-Cell Engager, in Prostate Cancer Patients
Jamie N Kuipers-Connarn, Arya Pourzanjani, Maitreyee Bose, et al.
Page
of 1